Regulatory volume decrease in Leishmania mexicana: effect of anti-microtubule drugs
Dagger, Francehuli; Valdivieso, Elizabeth; Marcano, Ana K; Ayesta, Carlos.
Mem. Inst. Oswaldo Cruz
; 108(1): 84-90, Feb. 2013. ilus, graf, tab
Artículo en Inglés | LILACS | ID: lil-666049
Documentos relacionados
Regulatory volume decrease in Leishmania mexicana: effect of anti-microtubule drugs.
Efflux identification and engineering for ansamitocin P-3 production in Actinosynnema pretiosum.
Biosynthesis of ansamitocin P-3 incurs stress on the producing strain Actinosynnema pretiosum at multiple targets.
Increased yield of AP-3 by inactivation of asm25 in Actinosynnema pretiosum ssp. auranticum ATCC 31565.
CRISPR-Cas9 screens identify regulators of antibody-drug conjugate toxicity.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Maytansinol Derivatives: Side Reactions as a Chance for New Tubulin Binders.
A highly potent maytansinoid analogue and its use as a cytotoxic therapeutic agent in gold nanoparticles for the treatment of hepatocellular carcinoma.
C3 ester side chain plays a pivotal role in the antitumor activity of Maytansinoids.
Evaluation of Targets for Maytansinoid ADC Therapy Using a Novel Radiochemical Assay.